Cannabis Stocks Surge as Trump Considers Rescheduling Marijuana
Dec 19, 2025, 6:52 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The potential federal legalization could lead to a massive sales increase for TLRY, similar to historical booms seen in the cannabis market post-regulatory changes. For example, when Canada legalized recreational cannabis, companies like Tilray saw substantial stock price increases.
AI summary
What happened, with direct paths to the underlying reporting
Cannabis stocks surged after Trump's rescheduling consideration. Tilray Brands' stock rose 27.54% on heightened investor optimism. Trading volume reached 525% above average, indicating strong market interest. Easing regulations and taxes could significantly impact cannabis industry growth.
Cannabis stocks surged after Trump's rescheduling consideration.
Tilray Brands' stock rose 27.54% on heightened investor optimism.
Easing regulations and taxes could significantly impact cannabis industry growth.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Tilray Brands' shares have experienced significant gains due to news of the Trump administration planning to reclassify marijuana as a Schedule III substance. This change is expec…
Tilray Brands has acquired BrewDog for $53 million, aiming to revitalize the brand's image and boost its craft beer sales. The CEO plans to leverage new sales strategies and partn…
Tilray will report Q2 earnings on Jan. 8, 2025. Analysts expect a loss of $0.20 per share this quarter. Revenue estimate remains unchanged at $210.95 million year-over-year. Share…